PDE5 inhibitors constitute the first-line treatment, while adjunctive TRT may be considered for hypogonadal non-responders, with careful attention to potential side effects, such as gastrointestinal symptoms, increased blood pressure, and thrombosis [206]
GIP receptor activation enhances insulin secretion, modulates adipose tissue metabolism, and appears to synergise with GLP-1 activity to produce greater metabolic effects than either hormone alone as demonstrated by the clinical performance of the dual agonist tirzepatide
These procedures when done at a stable weight will give more defined shapes, less post op risks and easier recovery so they are great for those who are committed to their health and appearance.
A recent study that was published in the New England Journal of Medicine (and also funded by Novo Nordisk) evaluated about 10,000 participants who had type 2 diabetes and also atherosclerosis or chronic kidney disease, or both
Named an Insurgent Brand by Bain & Company in 2025 and 2026, Force Factor is recognized as a high-growth innovator reshaping the health and wellness category
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Ceriello A, et al